Back to CHARLES SCHWAB INVESTMENT MANAGEMENT INC CHARLES SCHWAB INVESTMENT MANAGEMENT INC

ZBIOZBIO
7 quarters

Position history for CHARLES SCHWAB INVESTMENT MANAGEMENT INCCHARLES SCHWAB INVESTMENT MANAGEMENT INC's holdings in ZENAS BIOPHARMA INC

Yes. Charles Schwab Investment Management holds 302,085 shares of ZBIO (Zenas Biopharma), worth $7.7M, as of its Q2 2026 13F filing. It increased the position by 77,683 shares (+34.6%) from Q1 2026. Charles Schwab Investment Management has held ZBIO since Q4 2024, across 7 quarterly 13F filings.

Current Value

$7.7M

Current Shares

302,085

Total Value Change

+$6.7M

Total Shares Change

+183,425

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
302,085
+34.6%
$7.7M0.0%$25.38
35
2026-Q1
Increased
224,402
+5.3%
$4.4M0.0%$25.18
28
2025-Q4
Increased
213,193
+19.5%
$7.7M0.0%$36.58
32
2025-Q3
Increased
178,396
+46.0%
$4M0.0%$20.57
36
2025-Q2
Increased
122,210
+5.2%
$1.2M0.0%$9.58
27
2025-Q1
Decreased
116,140
-2.1%
$917,5060.0%$8.17
0
2024-Q4
New
118,660
-
$971,8250.0%$8.99
35

Other major holders of ZBIO: FMR LLC, FEDERATED HERMES, INC.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used